• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 associated pulmonary thrombosis.

作者信息

van Nieuwkoop C

机构信息

Dept. of Internal Medicine, Haga Teaching Hospital, The Hague, the Netherlands.

出版信息

Thromb Res. 2020 Jul;191:151. doi: 10.1016/j.thromres.2020.04.042. Epub 2020 May 1.

DOI:10.1016/j.thromres.2020.04.042
PMID:32386985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7252089/
Abstract
摘要

相似文献

1
COVID-19 associated pulmonary thrombosis.新型冠状病毒肺炎相关肺血栓形成
Thromb Res. 2020 Jul;191:151. doi: 10.1016/j.thromres.2020.04.042. Epub 2020 May 1.
2
Severe arterial thrombosis associated with Covid-19 infection.严重的动脉血栓与新冠病毒感染有关。
Thromb Res. 2020 Aug;192:75-77. doi: 10.1016/j.thromres.2020.05.025. Epub 2020 May 16.
3
A case of COVID-19 pneumonia with cerebral hemorrhage.一例新型冠状病毒肺炎合并脑出血病例。
Thromb Res. 2020 Sep;193:22-24. doi: 10.1016/j.thromres.2020.05.050. Epub 2020 May 30.
4
Pulmonary embolism in a young pregnant woman with COVID-19.一名感染新冠病毒的年轻孕妇发生肺栓塞
Thromb Res. 2020 Jul;191:36-37. doi: 10.1016/j.thromres.2020.04.022. Epub 2020 Apr 20.
5
Analysis of incidence of thrombotic complications in the presence of competing risks.存在竞争风险时血栓形成并发症发生率的分析。
Thromb Res. 2020 Jul;191:152. doi: 10.1016/j.thromres.2020.04.045. Epub 2020 May 3.
6
Thrombosis and COVID-19 pneumonia: the clot thickens!血栓与 COVID-19 肺炎：凝块变厚！
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01608-2020. Print 2020 Jul.
7
Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry.使用旋转血栓弹力图对新型冠状病毒肺炎相关的高凝状态进行筛查。
J Clin Anesth. 2020 Dec;67:109976. doi: 10.1016/j.jclinane.2020.109976. Epub 2020 Jul 4.
8
How to evaluate intensive care unit performance during the COVID-19 pandemic.如何评估新冠疫情期间重症监护病房的绩效。
Rev Bras Ter Intensiva. 2020 Jun;32(2):203-206. doi: 10.5935/0103-507x.20200040. Epub 2020 Jul 13.
9
Where do we stand with antithrombotic prophylaxis in patients with COVID-19?对于新冠肺炎患者的抗血栓预防，我们目前处于什么阶段？
Thromb Res. 2020 Jul;191:29. doi: 10.1016/j.thromres.2020.04.023. Epub 2020 Apr 20.
10
Thrombotic complications in critically ill patients with COVID 19.新型冠状病毒肺炎（COVID-19）危重症患者的血栓形成并发症
Thromb Res. 2020 Jul;191:56. doi: 10.1016/j.thromres.2020.04.032. Epub 2020 Apr 30.

引用本文的文献

1
Mechanics and microstructure of blood plasma clots in shear driven rupture.剪切驱动破裂中血浆凝块的力学和微观结构。
Soft Matter. 2024 May 29;20(21):4184-4196. doi: 10.1039/d4sm00042k.
2
Emerging patterns of hypercoagulability associated with critical COVID-19: A review.与重症新型冠状病毒肺炎相关的高凝状态新趋势：综述
Trends Anaesth Crit Care. 2020 Oct;34:4-13. doi: 10.1016/j.tacc.2020.07.004. Epub 2020 Jul 9.
3
COVID-19-Associated Thrombotic Complication: Is It Pulmonary Embolism or In Situ Thrombosis?新型冠状病毒肺炎相关血栓并发症：是肺栓塞还是原位血栓形成？
Radiol Res Pract. 2023 Jul 3;2023:3844069. doi: 10.1155/2023/3844069. eCollection 2023.
4
Identification of 3 key genes as novel diagnostic and therapeutic targets for OA and COVID-19.鉴定 3 个关键基因作为 OA 和 COVID-19 的新型诊断和治疗靶点。
Front Immunol. 2023 May 22;14:1167639. doi: 10.3389/fimmu.2023.1167639. eCollection 2023.
5
Risk stratification and prognostic value of prothrombin time and activated partial thromboplastin time among COVID-19 patients.COVID-19 患者凝血酶原时间和活化部分凝血活酶时间的风险分层和预后价值。
PLoS One. 2022 Aug 11;17(8):e0272216. doi: 10.1371/journal.pone.0272216. eCollection 2022.
6
Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.Covid-19：从脆弱性、合并症和疫苗接种的角度探讨各种治疗方法的药物治疗见解。
Inflammopharmacology. 2022 Feb;30(1):1-21. doi: 10.1007/s10787-021-00904-w. Epub 2022 Jan 3.
7
Contrast echocardiography facilitates appropriate management of hospitalized patients with coronavirus disease 2019 (COVID-19) and suspected right ventricular masses: case series.对比增强超声心动图有助于对2019冠状病毒病（COVID-19）住院患者及疑似右心室肿块进行适当管理：病例系列
Eur Heart J Case Rep. 2021 Mar 10;5(3):ytaa575. doi: 10.1093/ehjcr/ytaa575. eCollection 2021 Mar.
8
Serial markers of coagulation and inflammation and the occurrence of clinical pulmonary thromboembolism in mechanically ventilated patients with SARS-CoV-2 infection; the prospective Maastricht intensive care COVID cohort.新型冠状病毒肺炎（SARS-CoV-2）感染的机械通气患者凝血和炎症的系列标志物与临床肺血栓栓塞的发生；前瞻性马斯特里赫特重症监护COVID队列研究
Thromb J. 2021 May 31;19(1):35. doi: 10.1186/s12959-021-00286-7.
9
COVID-19 as a mediator of interferon deficiency and hyperinflammation: Rationale for the use of JAK1/2 inhibitors in combination with interferon.COVID-19 作为干扰素缺乏和炎症过度活跃的中介：联合使用 JAK1/2 抑制剂与干扰素的原理。
Cytokine Growth Factor Rev. 2021 Aug;60:28-45. doi: 10.1016/j.cytogfr.2021.03.006. Epub 2021 Apr 14.
10
COVID-19 and Hematology-What Do We Know So Far?新型冠状病毒肺炎与血液学——我们目前了解到了什么？
SN Compr Clin Med. 2020;2(12):2631-2636. doi: 10.1007/s42399-020-00607-3. Epub 2020 Oct 27.

本文引用的文献

1
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.微血管性新冠肺炎肺血管阻塞性血栓炎症综合征（MicroCLOTS）：一种非典型急性呼吸窘迫综合征的工作假说。
Crit Care Resusc. 2020 Apr 15;22(2):95-97. doi: 10.51893/2020.2.pov2.
2
Incidence of thrombotic complications in critically ill ICU patients with COVID-19.COVID-19 重症监护病房危重症患者的血栓并发症发生率。
Thromb Res. 2020 Jul;191:145-147. doi: 10.1016/j.thromres.2020.04.013. Epub 2020 Apr 10.
3
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.抗凝治疗与伴有凝血功能障碍的严重 2019 冠状病毒病患者的死亡率降低相关。
J Thromb Haemost. 2020 May;18(5):1094-1099. doi: 10.1111/jth.14817. Epub 2020 Apr 27.
4
The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.接触激活和激肽释放酶/激肽系统：病理生理和生理活性。
J Thromb Haemost. 2016 Jan;14(1):28-39. doi: 10.1111/jth.13194. Epub 2016 Jan 11.
5
Pulmonary embolism.肺栓塞
N Engl J Med. 1998 Jul 9;339(2):93-104. doi: 10.1056/NEJM199807093390207.